Published 3 months ago

Gland Pharma’s Hyderabad Facility Gets Two US FDA Observations

Summary by NDTV Profit

Gland Pharma Ltd. announced on Thursday that the United States Food and Drug Administration conducted surprise inspection on the company’s Dundigal Facility at Hyderabad for Good Manufacturing Practices between July 22 to July 25. The inspection was concluded with two 483 Observations, as per an exchange filing.These observations are procedural in nature. The corrective and preventive actions for these observations will be submitted to the US FD…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated3 months agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Gland Pharma’s Hyderabad Facility Gets Two US FDA Observations

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics